Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100681572 | 10068157 | 2 | F | 201305 | 20150326 | 20140409 | 20150331 | PER | US-PFIZER INC-2014096992 | PFIZER | 64.00 | YR | F | Y | 83.90000 | KG | 20150331 | N | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100681572 | 10068157 | 1 | PS | SUTENT | SUNITINIB MALATE | 1 | 37.5 MG, CYCLIC | D | 21938 | 37.5 | MG | CAPSULE, HARD | |||||||
| 100681572 | 10068157 | 2 | C | CALCIUM | CALCIUM | 1 | UNK | D | 0 | ||||||||||
| 100681572 | 10068157 | 3 | C | SIMVASTATIN. | SIMVASTATIN | 1 | UNK | D | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 100681572 | 10068157 | 1 | Carcinoid tumour |
| 100681572 | 10068157 | 2 | Bone cancer |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 100681572 | 10068157 | Carcinoid tumour | |
| 100681572 | 10068157 | Disease progression | |
| 100681572 | 10068157 | Product use issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 100681572 | 10068157 | 1 | 201305 | 0 |